Retina Implant Completes €26M Equity Funding Round

Retina Implant AG, a Reutlingen, Germany-based developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), completed a €26m round of equity funding.

Investors included Max Reindl, former founder and CEO of Wavelight Laser Technologies, now part of Alcon.

The company intends to use the funds to initiate reimbursement applications for its CE marked Alpha IMS subretinal microchip in key markets.

Founded by Dr. Eberhart Zrenner, professor of Ophthalmology, University of Tübingen, Germany and his colleagues in 2003, and led by Dr. Walter-G Wrobel, CEO, Retina Implant develops subretinal implants for partially sighted and blind patients. The company began implanting human patients in 2005 and started a second, larger clinical trial in 2010. In July 2013, its wireless subretinal implant technology, Alpha IMS, received CE mark.



Join the discussion